Original Investigation

Artificial Intelligence Model for Imaging-Based Extranodal Extension Detection and Outcome Prediction in Human Papillomavirus−Positive Oropharyngeal Cancer

JAMA Otolaryngology–Head & Neck Surgery 10.1001/jamaoto.2025.3225

September 30, 2025 at 11:20 AM EDT

Read the full article

Can an artificial intelligence (AI)−driven model predict imaging-based extranodal extension (iENE) and oncologic outcomes from pretreatment computed tomography scans of patients with human papillomavirus (HPV)−positive oropharyngeal squamous cell carcinoma (OPSCC)?In this single-center cohort study of 397 patients with HPV-positive cN OPSCC, an automated pipeline integrating lymph node segmentation and iENE classification achieved an area under the receiver operating characteristic curve of 0.81. AI-predicted iENE was significantly associated with worse distant failure, recurrence-free survival, and overall survival, and outperformed expert radiologist assessment.These findings suggest that automated iENE detection using AI models may offer a powerful prognostic tool to complement clinical decision-making in HPV-positive OPSCC and extend iENE interpretation capabilities to centers that lack specialized radiologists.

Corresponding Author: Laurent Letourneau-Guillon, MD, MSc, Centre Hospitalier de l’Université de Montréal, 1051 Rue Sanguinet, Montréal, QC H2X 3E4, Canada (laurent.letourneau-guillon.1@umontreal.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2025.3225?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=093025

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks